For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...
Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...
JACK FITZWATER has revealed how he thought his football career was in jeopardy when he was forced to visit the toilet 40 times a day. The defender hopes to help League One club Exeter topple ...
SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...